Currently, there are 377.00M common shares owned by the public and among those 245.28M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -10.59% and -17.05% over the past three months. GAP shares are trading -14.98% year to date (YTD), with the 12-month market performance up to 6.07% higher. It has a 12-month low price of $18.95 and touched a high of $30.75 over the same period. GAP has an average intraday trading volume of 4.82 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -10.88%, -14.11%, and -12.37% respectively.
Institutional ownership of Gap, Inc (NYSE: GAP) shares accounts for 63.39% of the company’s 377.00M shares outstanding.
It has a market capitalization of $7.58B and a beta (3y monthly) value of 2.16. The stock’s trailing 12-month PE ratio is 9.34, while the earnings-per-share (ttm) stands at $2.15. The company has a PEG of 0.49 and a Quick Ratio of 0.84 with the debt-to-equity ratio at 1.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.75% over the week and 3.77% over the month.
Earnings per share for the fiscal year are expected to increase by 42.61%, and 6.21% over the next financial year. EPS should grow at an annualized rate of 18.99% over the next five years, compared to -12.38% over the past 5-year period.
Looking at the support for the GAP, a number of firms have released research notes about the stock. Argus stated their Buy rating for the stock in a research note on January 21, 2025, with the firm’s price target at $27. UBS coverage for the Gap, Inc (GAP) stock in a research note released on January 10, 2025 offered a Neutral rating with a price target of $26. JP Morgan was of a view on December 02, 2024 that the stock is Overweight, while Telsey Advisory Group gave the stock Market Perform rating on August 30, 2024, issuing a price target of $29- $26. BofA Securities on their part issued Neutral rating on July 31, 2024.
